Cargando…

Recurrence of SARS-CoV-2 nucleic acid positive test in patients with COVID-19: a report of two cases

BACKGROUND: The recurrence of positive SARS-CoV-2 nucleic acid test results in patients with COVID-19 is becoming more important and warrants more attention. CASE PRESENTATION: This study reports 2 cases, a child with mild COVID-19 and an adult female with moderate COVID-19, who were discharged afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jian, Cheng, Juan, Shi, Xiaowei, Liu, Jun, Huang, Biao, Zhao, Xinguo, Qiu, Yuanwang, Yu, Jiong, Cao, Hongcui, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681189/
https://www.ncbi.nlm.nih.gov/pubmed/33225932
http://dx.doi.org/10.1186/s12890-020-01348-8
Descripción
Sumario:BACKGROUND: The recurrence of positive SARS-CoV-2 nucleic acid test results in patients with COVID-19 is becoming more important and warrants more attention. CASE PRESENTATION: This study reports 2 cases, a child with mild COVID-19 and an adult female with moderate COVID-19, who were discharged after three consecutive negative nucleic acid tests and were later readmitted to the hospital for recurrence of SARS-CoV-2 nucleic acid positivity. By tracking the patients’ symptoms, serum antibodies, and imaging manifestations after readmission, we found that they showed a trend of gradual improvement and recovery throughout treatment. They were cured without additional treatment, with the appearance of antibodies and the recovery of immune functions. CONCLUSIONS: It is deemed extremely necessary to improve the discharge standard of care. At the same time, nucleic acid detection is recommended to increase the dynamic monitoring of serum antibodies and imaging, strengthen the management of discharged patients, and appropriately extend the home or centralized isolation time. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-020-01348-8.